Lyell Immunopharma, Inc. (LYEL) News
Follow Lyell Immunopharma, Inc. (LYEL) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Lyell Immunopharma completes manufacturing transfer for LYL273
EQUITY | Sep 10, 2026, 08:05 PM UTC
L
LYEL new Buy W/ $44 PT @ BRiley
LYEL new Buy W/ $44 PT @ BRiley
EQUITY | Jul 22, 2026, 01:21 PM UTC
L
LYEL Initiated Buy W/$44.00 PT at B.Riley
LYEL Initiated Buy W/$44.00 PT at B.Riley
EQUITY | Jul 22, 2026, 12:02 PM UTC